Clinical trial

PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome

NCT02037672

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-09-01

PhasePHASE4

Study timeline

Study start (unknown)2013-09-01Date precision: month

Registry last updated2014-01-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PCOSunresolved

Obesityunresolved

Interventions

metforminDRUG · verified · RxNorm: metformin

metformin and roflumilastDRUG

Sponsors & collaborators

University Medical Centre Ljubljanalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02037672 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.